5/28/2014 9:57:19 AM
SAN DIEGO, May 27, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the field of SERCA enzymes, today announced that Krisztina Zsebo, Ph.D., President and Chief Executive Officer, will present a corporate overview at the Jefferies 2014 Global Healthcare Conference, being held at the Grand Hyatt Hotel in New York City.
Help employers find you! Check out all the jobs and post your resume.
comments powered by